NCT05429749View on ClinicalTrials.gov

Intravenous Iron Supplement to Prevent Postoperative Delirium After Hip Fracture Surgery

PHASE4UnknownINTERVENTIONAL
Enrollment

264

Participants

Timeline

Start Date

July 30, 2020

Primary Completion Date

December 31, 2023

Study Completion Date

December 31, 2024

Conditions
Hip Fractures
Interventions
DRUG

Ferinject

Intravenous ferinject 1000mg is administered between the admission day and the surgery day.

DRUG

Normal saline

Normal saline 250ml is administered between the admission day and the surgery day.

Trial Locations (1)

13620

RECRUITING

Seoul National University Bundang Hospital, Seongnam

Sponsors

Collaborators (1)

JW Pharmaceutical
All Listed Sponsors
collaborator

JW Pharmaceutical

INDUSTRY

lead

Seoul National University Bundang Hospital

OTHER

NCT05429749 - Intravenous Iron Supplement to Prevent Postoperative Delirium After Hip Fracture Surgery | Biotech Hunter | Biotech Hunter